Results: 15
Predicting prognosis using a pathological tumor cell proportion in stage I lung adenocarcinoma.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 10, p. 1525, doi. 10.1111/1759-7714.14427
- By:
- Publication type:
- Article
Mubritinib enhanced the inhibiting function of cisplatin in lung cancer by interfering with mitochondrial function.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 10, p. 1513, doi. 10.1111/1759-7714.14425
- By:
- Publication type:
- Article
The optimal therapy strategy for epidermal growth factor receptor‐mutated non‐small cell lung cancer patients with brain metastasis: A real‐world study from Taiwan.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 10, p. 1505, doi. 10.1111/1759-7714.14423
- By:
- Publication type:
- Article
Impact of losing adipose tissue on outcomes from PD‐1/PD‐L1 inhibitor monotherapy in non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 10, p. 1496, doi. 10.1111/1759-7714.14421
- By:
- Publication type:
- Article
Prognostic value of preoperative plasma fibrinogen levels in resected stage I non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 10, p. 1490, doi. 10.1111/1759-7714.14419
- By:
- Publication type:
- Article
Pretreatment body mass index predicts survival among patients administered nivolumab monotherapy for pretreated non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 10, p. 1479, doi. 10.1111/1759-7714.14417
- By:
- Publication type:
- Article
Femoral brucellosis mimicking a tumor.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 10, p. 1541, doi. 10.1111/1759-7714.14416
- By:
- Publication type:
- Article
Clinical efficacy of dacomitinib in rechallenge setting for patients with epidermal growth factor receptor mutant non–small cell lung cancer: A multicenter retrospective analysis (TOPGAN2020‐02).
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 10, p. 1471, doi. 10.1111/1759-7714.14415
- By:
- Publication type:
- Article
A phase II study of anlotinib combined with etoposide and platinum‐based regimens in the first‐line treatment of extensive‐stage small cell lung cancer.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 10, p. 1463, doi. 10.1111/1759-7714.14414
- By:
- Publication type:
- Article
Two‐port robotic sleeve lobectomy using Stratafix sutures for central lung tumors.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 10, p. 1457, doi. 10.1111/1759-7714.14412
- By:
- Publication type:
- Article
Comparison of the analytical performance of the Oncomine dx target test focusing on bronchoscopic biopsy forceps size in non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 10, p. 1449, doi. 10.1111/1759-7714.14411
- By:
- Publication type:
- Article
Elevated BTG2 improves the radiosensitivity of non‐small cell lung cancer (NSCLC) through apoptosis.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 10, p. 1441, doi. 10.1111/1759-7714.14410
- By:
- Publication type:
- Article
Single utility port approach in robot‐assisted sleeve segmentectomy for bronchial carcinoid tumor.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 10, p. 1537, doi. 10.1111/1759-7714.14409
- By:
- Publication type:
- Article
Thymoma exhibiting spontaneous regression with developing myasthenia gravis: A case report.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 10, p. 1533, doi. 10.1111/1759-7714.14407
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 10, p. 1439, doi. 10.1111/1759-7714.14024
- Publication type:
- Article